Peripheral Intervention Drugeluting Devices Market Size, Share, Industry Trends and Forecast to 2030

Peripheral Intervention Drug-eluting Devices Market Size & CAGR in 2021

In 2021, the global peripheral intervention drug-eluting devices market is estimated to have a market size of USD 1.5 billion with a compound annual growth rate (CAGR) of 4.2%.

COVID-19 Impact on the Peripheral Intervention Drug-eluting Devices Market

The outbreak of COVID-19 in 2020 had a significant impact on the peripheral intervention drug-eluting devices market. The market witnessed a temporary decline due to disruptions in the supply chain and delays in elective procedures. However, the market is gradually recovering as healthcare services resume.

Peripheral Intervention Drug-eluting Devices Dynamics

The peripheral intervention drug-eluting devices market is driven by the increasing prevalence of peripheral artery disease (PAD) and the growing adoption of minimally invasive procedures. Technological advancements in drug-eluting devices are further fueling market growth.

Segments and Related Analysis

The market for peripheral intervention drug-eluting devices is segmented based on product type, end-user, and region. Product segments include drug-eluting stents, drug-eluting balloons, and drug-eluting catheters. End-users of these devices include hospitals, ambulatory surgical centers, and specialty clinics.

By Region Analysis

The market for peripheral intervention drug-eluting devices is divided into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America currently dominates the market, followed by Europe and Asia Pacific.

Key Market Players and Competitive Landscape

Key players in the peripheral intervention drug-eluting devices market include Medtronic, Boston Scientific, Abbott Laboratories, Becton Dickinson, and Cook Medical. These companies are focusing on product innovation and strategic partnerships to maintain their market position.

Recent Happenings in the Peripheral Intervention Drug-eluting Devices Market

In recent developments, Boston Scientific launched a new drug-eluting stent for peripheral artery disease, while Medtronic announced a partnership with a leading research institute to develop advanced drug-eluting catheters. These innovations are expected to drive market growth and offer better treatment options for patients.